Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601 · cited 1×
“…are essential steps in the carcinogenesis of colon carcinoma, medulloblastoma, pilomatricoma, thyroid carcinoma, hepatocellular carcinoma and other malignancies (Tetsu and McCormick, 1999; Hamilton et al., 1995; Chan et al., 1999; Zurawel et al., 1998; Garcia et al., 1999; Ogawa et al., 1999).”
Backgroundβ-catenin: a key mediator of Wnt signaling
Willert, K., & Nusse, R. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80068-3 · Cited by 753 · cited 1×
“Activation of Wnt signaling leads to the accumulation of free b-catenin in the cytosol and, thereby, enables b-catenin to translocate into the nucleus (Willert and Nusse, 1998; Dierick and Bejsovec, 1999).”
BackgroundA common human skin tumour is caused by activating mutations in β-catenin
Chan, E., Gat, U., McNiff, J. M., & Fuchs, E. (1999) · Nature Genetics · doi:10.1038/7747 · Cited by 612 · cited 1×
“…are essential steps in the carcinogenesis of colon carcinoma, medulloblastoma, pilomatricoma, thyroid carcinoma, hepatocellular carcinoma and other malignancies (Tetsu and McCormick, 1999; Hamilton et al., 1995; Chan et al., 1999; Zurawel et al., 1998; Garcia et al., 1999; Ogawa et al., 1999).”
BackgroundFrzb, a Secreted Protein Expressed in the Spemann Organizer, Binds and Inhibits Wnt-8
Wang, S., Krinks, M., Lin, K., Luyten, F. P., & Moos, M. (1997) · Cell · doi:10.1016/s0092-8674(00)81922-4 · Cited by 518 · cited 1×
“However, this signaling pathway can be modulated by a recently identi®ed group of soluble proteins, the soluble Frizzled-related proteins (sFRPs; secreted apoptosis-related proteins, SARPs) (Wang et al., 1997; Leyns et al., 1997; Rattner et al., 1997; Finch et al., 1997; Melkonyan et al., 1997).”
Background
Cited by
Secreted antagonists of the Wnt signalling pathway
Kawano, Y., & Kypta, R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00623 · Cited by 1,584
“Although neither sFRP affects glioma cell proliferation nor sensitivity to apoptotic stimuli in vitro, they both confer resistance to serum starvation, and sFRP2 (but not sFRP1) promotes tumour growth in nude mice (Roth et al., 2000).”
BackgroundVescovi, A. L., Galli, R., & Reynolds, B. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1889 · Cited by 990
A highlight on Sonic hedgehog pathway
Carballo, G. B., Honorato, J. R., de Lopes, G. P. F., & Spohr, T. C. L. D. S. E. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0220-7 · Cited by 460
Secreted Frizzled‐related proteins: searching for relationships and patterns
Jones, S. E., & Jomary, C. (2002) · BioEssays · doi:10.1002/bies.10136 · Cited by 427
Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2
Oshima, T., Abe, M., Asano, J., Hara, T., Kitazoe, K., Sekimoto, E., Tanaka, Y., Shibata, H., Hashimoto, T., Ozaki, S., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4940 · Cited by 345
Aubert, J., Dunstan, H., Chambers, I., & Smith, A. (2002) · Nature Biotechnology · doi:10.1038/nbt763 · Cited by 325
The significance of the Wnt pathway in the pathology of human cancers
Karim, R. Z., Tse, G. M. K., Putti, T. C., Scolyer, R. A., & Soon Lee, C. (2004) · Pathology · doi:10.1080/00313020410001671957 · Cited by 276
WNT signaling in glioblastoma and therapeutic opportunities
Lee, Y., Lee, J.-K., Ahn, S. H., Lee, J., & Nam, D.-H. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.140 · Cited by 273
Verdugo, E., Puerto, I., & Medina, M. Á. (2022) · Cancer Communications · doi:10.1002/cac2.12361 · Cited by 253
Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma
Merle, P., de la Monte, S., Kim, M., Herrmann, M., Tanaka, S., Von Dem Bussche, A., Kew, M. C., Trepo, C., & Wands, J. R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.009 · Cited by 249
Lee, A. Y., He, B., You, L., Dadfarmay, S., Xu, Z., Mazieres, J., Mikami, I., McCormick, F., & Jablons, D. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207881 · Cited by 209
“Additionally, while previous studies have shown that sFRP overexpression induces apoptosis, Roth et al. (2000) have recently shown that sFRPs promote growth and survival of human malignant glioma cells.”
BackgroundZi, X., Guo, Y., Simoneau, A. R., Hope, C., Xie, J., Holcombe, R. F., & Hoang, B. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0103 · Cited by 196
“clonogenicity and enhanced resistance to serum starvation in glioma cell lines (42), whereas sFRP4 decreased the colony formation of glioma cells in soft agar (11).”
The role of Pax6 in forebrain development
Georgala, P. A., Carr, C. B., & Price, D. J. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20895 · Cited by 181
“SFRP-2 has been shown to inhibit migration of malignant glioma cells in vitro (Roth et al., 2000) and so may have a role in limiting dorsal migration at the PSPB.”
BackgroundShou, J., Ali-Osman, F., Multani, A. S., Pathak, S., Fedi, P., & Srivenugopal, K. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205138 · Cited by 164
“Additionally, the fact that U87MG cells harbor a wild-type p53 (Van Meir et al., 1994), and possess an intact Wnt signaling pathway (Roth et al., 2000) provided an appropriate design for our study.”
MethodZhang, W., Zhang, K., Ma, Y., Song, Y., Qi, T., Xiong, G., Zhang, Y., Kan, C., Zhang, J., Han, F., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115344 · Cited by 22
Metadata
- Authors
- Roth, W., Wild-Bode, C., Platten, M., Grimmel, C., Melkonyan, H. S., Dichgans, J., & Weller, M.
- Venue
- Oncogene
- Published
- 2000-08-31
- Volume
- 19
- Issue
- 37
- Pages
- 4210-4220
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2332316926
- Cited by
- 170
- References
- 4
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.